BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 18312546)

  • 1. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.
    Shibata N; Kawaguchi-Niida M; Yamamoto T; Toi S; Hirano A; Kobayashi M
    Neuropathology; 2008 Aug; 28(4):387-98. PubMed ID: 18312546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of STAT3 and inhibitory effects of pioglitazone on STAT3 activity in a mouse model of SOD1-mutated amyotrophic lateral sclerosis.
    Shibata N; Yamamoto T; Hiroi A; Omi Y; Kato Y; Kobayashi M
    Neuropathology; 2010 Aug; 30(4):353-60. PubMed ID: 19925559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis.
    Kiaei M; Kipiani K; Chen J; Calingasan NY; Beal MF
    Exp Neurol; 2005 Feb; 191(2):331-6. PubMed ID: 15649489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis.
    Fontanilla CV; Gu H; Liu Q; Zhu TZ; Zhou C; Johnstone BH; March KL; Pascuzzi RM; Farlow MR; Du Y
    Sci Rep; 2015 Nov; 5():16953. PubMed ID: 26586020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-bound crotonaldehyde accumulates in the spinal cord of superoxide dismutase-1 mutation-associated familial amyotrophic lateral sclerosis and its transgenic mouse model.
    Shibata N; Kawaguchi M; Uchida K; Kakita A; Takahashi H; Nakano R; Fujimura H; Sakoda S; Ihara Y; Nobukuni K; Takehisa Y; Kuroda S; Kokubo Y; Kuzuhara S; Honma T; Mochizuki Y; Mizutani T; Yamada S; Toi S; Sasaki S; Iwata M; Hirano A; Yamamoto T; Kato Y; Sawada T; Kobayashi M
    Neuropathology; 2007 Feb; 27(1):49-61. PubMed ID: 17319283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
    Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
    Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice.
    Schütz B; Reimann J; Dumitrescu-Ozimek L; Kappes-Horn K; Landreth GE; Schürmann B; Zimmer A; Heneka MT
    J Neurosci; 2005 Aug; 25(34):7805-12. PubMed ID: 16120782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic administration of scAAV9-IGF1 extends survival in SOD1
    Wang W; Wen D; Duan W; Yin J; Cui C; Wang Y; Li Z; Liu Y; Li C
    Brain Res Bull; 2018 May; 139():203-210. PubMed ID: 29499331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased phospho-adducin immunoreactivity in a murine model of amyotrophic lateral sclerosis.
    Shan X; Hu JH; Cayabyab FS; Krieger C
    Neuroscience; 2005; 134(3):833-46. PubMed ID: 15994023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.
    Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE
    Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.
    Wootz H; Weber E; Korhonen L; Lindholm D
    Neuroscience; 2006 Dec; 143(2):419-30. PubMed ID: 16973300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peroxisome proliferator-activated receptor gamma agonist attenuates neurological deficits following spinal cord ischemia in rats.
    Kim H; Hwang J; Park S; Nahm SF; Min S; Lim C; Park K; Han S
    J Vasc Surg; 2014 Apr; 59(4):1084-9. PubMed ID: 23830318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of programmed cell death markers in ventral horn motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in a transgenic mouse model.
    Wengenack TM; Holasek SS; Montano CM; Gregor D; Curran GL; Poduslo JF
    Brain Res; 2004 Nov; 1027(1-2):73-86. PubMed ID: 15494159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression.
    Tortarolo M; Veglianese P; Calvaresi N; Botturi A; Rossi C; Giorgini A; Migheli A; Bendotti C
    Mol Cell Neurosci; 2003 Jun; 23(2):180-92. PubMed ID: 12812752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of aromatase expression in the spinal cord of an animal model of familial ALS.
    Sun C; Liu Y; Liu Y; Zhao M; Zhai J; Hao P; Wang Y; Ji Y
    Brain Res Bull; 2017 Jun; 132():180-189. PubMed ID: 28583855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of a SOD1-peptide immunotherapy on SOD1 G93A mouse slow model of amyotrophic lateral sclerosis.
    Sábado J; Casanovas A; Rodrigo H; Arqué G; Esquerda JE
    Neuroscience; 2015 Dec; 310():38-50. PubMed ID: 26384962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arctigenin derivative A-1 ameliorates motor dysfunction and pathological manifestations in SOD1
    Xiong B; Yang C; Yang X; Luo S; Li S; Chen C; He K; Nie L; Li P; Li S; Huang H; Liu J; Zhang Z; Xie Y; Zou L; Yang X
    CNS Neurosci Ther; 2024 Jun; 30(6):e14692. PubMed ID: 38872258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory effects of electroacupuncture in the respiratory system of a symptomatic amyotrophic lateral sclerosis animal model.
    Jiang JH; Yang EJ; Baek MG; Kim SH; Lee SM; Choi SM
    Neurodegener Dis; 2011; 8(6):504-14. PubMed ID: 21849797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.